Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
J R Coll Physicians Edinb ; 49(2): 118-121, 2019 Jun.
Article in English | MEDLINE | ID: mdl-31188339

ABSTRACT

Giant cell arteritis is the most common primary systemic vasculitis in adults aged ≥50 years and peaks in the eighth decade of life. Common symptoms include headache, scalp tenderness and jaw claudication. Elevated acute phase reactants (erythrocyte sedimentation rate and C-reactive protein) are present in >90% of patients. Visual loss is a well-recognised complication, but approximately 2-4% of giant cell arteritis patients experience stroke, most frequently in the vertebrobasilar territory. We describe a 72-year-old male who developed bilateral vertebral artery occlusion and middle cerebellar peduncle infarction secondary to giant cell arteritis in spite of high-dose steroids.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Giant Cell Arteritis/drug therapy , Methylprednisolone/therapeutic use , Vertebrobasilar Insufficiency/complications , Aged , Antirheumatic Agents/therapeutic use , Cerebral Infarction/diagnostic imaging , Cerebral Infarction/etiology , Cyclophosphamide/therapeutic use , Giant Cell Arteritis/complications , Humans , Male
3.
Br J Neurosurg ; 25(5): 632-5, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21848440

ABSTRACT

INTRODUCTION: The placement of external ventricular drain (EVD) is a common neurosurgical procedure to drain cerebrospinal fluid (CSF) in many acute neurosurgical conditions that disrupt the normal CSF absorption pathway. Infection is the primary complication with infection rates ranging between 0% and 45%, and this is associated with significant morbidity and mortality, prolonged hospital stay and increased hospital costs.This article compares and discusses the differences in rates of EVD CSF infection between clinical neurosurgical practice and the infection rates in a group of research patients where EVDs were sampled frequently as part of the study. MATERIALS AND METHODS: Patients who had EVD placed were identified by review of theatre logs from 2005-2008. A retrospective case-note review was performed with the primary end point being those patients treated with intrathecal antibiotics. Patients within the research group were identified from established data and the same primary endpoint was used. A standard silicone catheter was the EVD used in both cohorts. Patients were excluded if the EVD was placed for diagnoses other than hydrocephalus associated with aneurysmal subarachnoid haemorrhage (SAH). RESULTS: Ninety-four patients had 156 EVDs placed within the clinical group, 49 patients were treated giving an infection rate within this group of 52.1% per patient and 31.4% per EVD. Thirty-nine patients had 39 EVDs placed within the research group, four patients were treated, the infection rate within this group was 10.3% per EVD, p = 0.0001. CONCLUSION: Sampling or irrigating ventricular drainage systems does not increase the risk of CNS infection providing the operator has appropriate experience and has used theatre standard aseptic technique.


Subject(s)
Catheters, Indwelling/adverse effects , Prosthesis-Related Infections/epidemiology , Subarachnoid Hemorrhage/surgery , Anti-Bacterial Agents/therapeutic use , Asepsis/methods , Cerebrospinal Fluid/microbiology , Clinical Competence , Clinical Protocols/standards , Drainage/adverse effects , Drainage/instrumentation , Female , Humans , Hydrocephalus/surgery , Male , Middle Aged , Prosthesis-Related Infections/prevention & control , Retrospective Studies , Risk Factors , Silicones , Specimen Handling/standards , Subarachnoid Hemorrhage/diagnosis , Treatment Outcome , Ventriculostomy/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...